檢索結果 - Steven I. Sherman

Refine Results
  1. 1
    Advances in Chemotherapy of Differentiated Epithelial and Medullary Thyroid Cancers

    Advances in Chemotherapy of Differentiated Epithelial and Medullary Thyroid Cancers 由 Steven I. Sherman

    出版 2009
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Targeted therapies for thyroid tumors

    Targeted therapies for thyroid tumors 由 Steven I. Sherman

    出版 2011
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    ENDOCRINE TUMOURS: Approach to the patient with advanced differentiated thyroid cancer

    ENDOCRINE TUMOURS: Approach to the patient with advanced differentiated thyroid cancer 由 M Schlumberger, Steven I. Sherman

    出版 2011
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Evolving Approaches to Patients with Advanced Differentiated Thyroid Cancer

    Evolving Approaches to Patients with Advanced Differentiated Thyroid Cancer 由 Bryan R. Haugen, Steven I. Sherman

    出版 2013
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Prognosis and Treatment of Brain Metastases in Thyroid Carcinoma

    Prognosis and Treatment of Brain Metastases in Thyroid Carcinoma 由 Alice C. Chiu, Ebrahim S. Delpassand, Steven I. Sherman

    出版 1997
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Follicular variant of papillary thyroid carcinoma. A clinicopathologic study

    Follicular variant of papillary thyroid carcinoma. A clinicopathologic study 由 Emile T. Tielens, Steven I. Sherman, Ralph H. Hruban, Paul W. Ladenson

    出版 1994
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    A Phase I Study of Cabozantinib (XL184) in Patients with Differentiated Thyroid Cancer

    A Phase I Study of Cabozantinib (XL184) in Patients with Differentiated Thyroid Cancer 由 Maria E. Cabanillas, Marcia S. Brose, Jaymes Holland, Kimberly Ferguson, Steven I. Sherman

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    The Safety of Incretin-Based Therapies—Review of the Scientific Evidence

    The Safety of Incretin-Based Therapies—Review of the Scientific Evidence 由 Daniel J. Drucker, Steven I. Sherman, Richard M. Bergenstal, John B. Buse

    出版 2011
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    In Papillary Thyroid Cancer, Preoperative Central Neck Ultrasound Detects Only Macroscopic Surgical Disease, But Negative Findings Predict Excellent Long-Term Regional Control and Survival

    In Papillary Thyroid Cancer, Preoperative Central Neck Ultrasound Detects Only Macroscopic Surgical Disease, But Negative Findings Predict Excellent Long-Term Regional Control and... 由 Mauricio A. Moreno, Beth S. Edeiken‐Monroe, Eric R. Siegel, Steven I. Sherman, Gary L. Clayman

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism.

    Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. 由 Paul W. Ladenson, Steven I. Sherman, Kenneth L. Baughman, Phillip E. Ray, Arthur M. Feldman

    出版 1992
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid Cancer

    Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid Cancer 由 Libero Santarpia, Adel K. El‐Naggar, Gilbert J. Cote, Jeffrey N. Myers, Steven I. Sherman

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Long-Term Outcome of Comprehensive Central Compartment Dissection in Patients with Recurrent/Persistent Papillary Thyroid Carcinoma

    Long-Term Outcome of Comprehensive Central Compartment Dissection in Patients with Recurrent/Persistent Papillary Thyroid Carcinoma 由 Gary L. Clayman, Garima Agarwal, Beth S. Edeiken, Steven G. Waguespack, Dianna Roberts, Steven I. Sherman

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits

    Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits 由 Daniel J. Drucker, Steven I. Sherman, Fred S. Gorelick, Richard M. Bergenstal, Robert S. Sherwin, John B. Buse

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Genetic alterations in the RAS/RAF/mitogen‐activated protein kinase and phosphatidylinositol 3‐kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma

    Genetic alterations in the RAS/RAF/mitogen‐activated protein kinase and phosphatidylinositol 3‐kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinom... 由 Libero Santarpia, Jeffrey N. Myers, Steven I. Sherman, Francesco Trimarchi, Gary L. Clayman, Adel K. El‐Naggar

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Central Hypothyroidism Associated with Retinoid X Receptor–Selective Ligands

    Central Hypothyroidism Associated with Retinoid X Receptor–Selective Ligands 由 Steven I. Sherman, Jayashree Gopal, Bryan R. Haugen, Alice C. Chiu, Kevin J. Whaley, Prem Nowlakha, Madeleine Duvic

    出版 1999
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Prognostic factors in patients with Hürthle cell neoplasms of the thyroid

    Prognostic factors in patients with Hürthle cell neoplasms of the thyroid 由 Luis Lopez‐Penabad, Alice C. Chiu, Ana O. Hoff, Pamela N. Schultz, Sonia Gaztambide, Nelson G. Ordóǹez, Steven I. Sherman

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Vemurafenib in patients with BRAFV600E-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial

    Vemurafenib in patients with BRAFV600E-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, pha... 由 Marcia S. Brose, Maria E. Cabanillas, Ezra E.W. Cohen, Lori J. Wirth, Todd Riehl, Huibin Yue, Steven I. Sherman, Eric J. Sherman

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Distant Metastases From Childhood Differentiated Thyroid Carcinoma: Clinical Course and Mutational Landscape

    Distant Metastases From Childhood Differentiated Thyroid Carcinoma: Clinical Course and Mutational Landscape 由 Marloes Nies, Rena Vassilopoulou‐Sellin, Roland L. Bassett, Sireesha Yedururi, Mark Zafereo, Maria E. Cabanillas, Steven I. Sherman, Thera P. Links, Steven G. Waguespack

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Rationale and design of DECISION: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer

    Rationale and design of DECISION: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced o... 由 Marcia S. Brose, Christopher M. Nutting, Steven I. Sherman, Young Kee Shong, Johannes W. A. Smit, Gerhard Reike, John Chung, J. Kalmus, Christian Kappeler, Martin Schlumberger

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Correlative analyses of <i>RET</i> and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer

    Correlative analyses of <i>RET</i> and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer 由 Steven I. Sherman, Douglas O. Clary, Rossella Elisei, Martin Schlumberger, Ezra E.W. Cohen, Patrick Schöffski, Lori J. Wirth, Milan Mangeshkar, Dana T. Aftab, Marcia S. Brose

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: